tiprankstipranks
Advertisement
Advertisement

ZVSA Stock Latest News

ZyVersa Therapeutics Announces $1 Million Convertible Note Financing
Company AnnouncementsZyVersa Therapeutics Announces $1 Million Convertible Note Financing
1M ago
8K
ZVSA
Zyversa Therapeutics Faces Financial Challenges Amid Drug Development
PremiumCompany Announcements
Zyversa Therapeutics Faces Financial Challenges Amid Drug Development
5M ago
ZVSA
ZyVersa Therapeutics Delays 10-Q Filing
PremiumCompany Announcements
ZyVersa Therapeutics Delays 10-Q Filing
5M ago
ZVSA
Zyversa Therapeutics’ Promising Phase 2a Study on DKD Treatment
PremiumCompany Announcements
Zyversa Therapeutics’ Promising Phase 2a Study on DKD Treatment
5M ago
ZVSA
ZyVersa Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
ZyVersa Therapeutics Faces Nasdaq Delisting Notice
7M ago
8K
ZVSA
ZyVersa Therapeutics highlights publication of data on inflammasome inhibitors
PremiumThe FlyZyVersa Therapeutics highlights publication of data on inflammasome inhibitors
7M ago
ZVSA
ZyVersa Therapeutics highlights lipidomic data in Alport Syndrome, DKD
Premium
The Fly
ZyVersa Therapeutics highlights lipidomic data in Alport Syndrome, DKD
7M ago
ZVSA
ZyVersa Therapeutics Reports Financial Challenges Amid Nasdaq Delisting
Premium
Company Announcements
ZyVersa Therapeutics Reports Financial Challenges Amid Nasdaq Delisting
8M ago
ZVSA
ZyVersa Therapeutics highlights data on role of lipotoxicity in DKD
PremiumThe Fly
ZyVersa Therapeutics highlights data on role of lipotoxicity in DKD
8M ago
ZVSA
ZyVersa Therapeutics reports Q2 EPS (46c) vs. ($3.31) last year
PremiumThe Fly
ZyVersa Therapeutics reports Q2 EPS (46c) vs. ($3.31) last year
8M ago
ZVSA
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
PremiumThe Fly
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
8M ago
ZVSA
ZyVersa Therapeutics Stock Approved for OTCQB Listing
PremiumCompany Announcements
ZyVersa Therapeutics Stock Approved for OTCQB Listing
8M ago
8K
ZVSA
ZyVersa CEO says ‘deeply committed’ to executing with discipline, urgency
PremiumThe FlyZyVersa CEO says ‘deeply committed’ to executing with discipline, urgency
9M ago
ZVSA
ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
Premium
Company Announcements
ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
9M ago
8K
ZVSA
ZyVersa Therapeutics Enters Warrant Exercise Agreement
Premium
Company Announcements
ZyVersa Therapeutics Enters Warrant Exercise Agreement
9M ago
8K
ZVSA
ZyVersa announces warrant inducement transaction for $2M in gross proceeds
PremiumThe Fly
ZyVersa announces warrant inducement transaction for $2M in gross proceeds
9M ago
ZVSA
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
PremiumThe Fly
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
9M ago
ZVSA
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
PremiumThe Fly
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
9M ago
ZVSA
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
PremiumThe Fly
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
9M ago
ZVSA
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
PremiumCompany AnnouncementsZyVersa Therapeutics Secures $10M Equity Purchase Agreement
9M ago
8K
ZVSA
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
Premium
The Fly
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
9M ago
ZVSA
ZyVersa Therapeutics Stockholders Approve Key Proposals
Premium
Company Announcements
ZyVersa Therapeutics Stockholders Approve Key Proposals
10M ago
8K
ZVSA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >